
Focus on gross profit contribution, increase our performance efficiency, lower the manufacturing costs, improve the synergy between departments, improve our operation under the new market norm and develop our healthcare business.
Develop our business based on existing products. With addition products from research and development and acquisition, bio-pharmaceutical business will be our future growth driver.
China Shineway Pharmaceutical Group principally involves in the development, manufacture and sales of modern Chinese medicines. Presently, It is the largest manufacturer of Qing Kai Ling Injection, Shen Mai Injection, and Wu Fu Xin Nao Qing Soft Capsule.

Sagen Sie China Shineway Pharmaceutical Group, dass Sie interessiert sind dort zu arbeiten, ihre persönlichen Informationen bleiben dabei anonym. Comparably gibt China Shineway Pharmaceutical Group die Gelegenheit, Sie anzustellen. Wenn es eine passende Stelle gibt, matchen wir diese.
Senden Sie ihnen eine Einladung, um die Unternehmenskultur zu bewerten.